Chances are good that there's somebody in your life who should be using a hearing aid. About 30 million adults in America need hearing aids, but only about 20% use them. Hearing loss is not just an ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Pfizer has won the ...

Less than three months into his tenure, Novo Nordisk’s new CEO has undeniably left his mark on the company, launching a sweeping restructuring drive and recently cutting in on Pfizer’s planned ...

Novo Nordisk has reported the mixed midphase results behind its push to enter a heart disease market served by Alnylam Pharmaceuticals, BridgeBio and Pfizer. The phase 2 trial compared two doses of ...

Amid Novo Nordisk and Pfizer’s whiplash contest for obesity biotech Metsera, Novo’s CEO has, quite literally, told his company's rival to put its money where its mouth is. “Novo Nordisk and Pfizer ...

Editor's note: This article has been updated to provide clarity on a head-to-head study Eli Lilly conducted on its candidate, orforglipron. A pill version under development of Novo Nordisk's (NVO) GLP ...

NEW YORK/LONDON, Nov 6 (Reuters) - The Pfizer (PFE.N), opens new tab and Novo Nordisk (NOVOb.CO), opens new tab battle for obesity drug developer Metsera (MTSR.O), opens new tab intensified on ...

Danish drugmaker Novo Nordisk A/S was at the forefront of the weight-loss injection boom as people discovered that its Ozempic shot, originally developed to treat diabetes, could help trim their ...

Nov 13 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab and Eli Lilly (LLY.N), opens new tab denied weight-loss drug partnership with Mangoceuticals (MGRX.O), opens new tab on Thursday, hours after ...

Novo Nordisk A/S shares have declined sharply, but the company remains profitable with a positive long-term growth outlook and a strong cash position. NVO's decision to walk away from the Metsera, Inc ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. President Trump last week ...

Eli Lilly and Novo Nordisk have become the latest pharma giants to strike price-reduction deals with the White House, agreeing to sell their weight loss drugs at cut-rate prices to patients in the U.S ...